GLYPRESSIN 1mg powder + solvent for injection medication leaflet

H01BA04 terlipressin • Systemic hormonal preparations, excluding sex hormones and insulins | Posterior pituitary lobe hormones | Vasopressin and analogues

Terlipressin is a medication primarily used for the treatment of esophageal variceal bleeding and type 1 hepatorenal syndrome, conditions associated with liver cirrhosis. It is a synthetic analog of vasopressin that works by constricting blood vessels, reducing blood flow to abdominal organs, and lowering pressure in the portal venous system.

In esophageal variceal bleeding, terlipressin helps stop the bleeding by reducing pressure in the esophageal varices. In hepatorenal syndrome, it improves kidney function by increasing renal perfusion. The medication is administered intravenously, usually in a hospital setting, under strict medical supervision.

Common side effects include transient high blood pressure, abdominal pain, diarrhea, nausea, and pallor. In rare cases, it may cause ischemia in extremities or organs. It is contraindicated in patients with severe cardiovascular diseases, such as heart failure or peripheral arterial disease.

General data about GLYPRESSIN 1mg

Substance: terlipressin

Date of last drug list: 01-06-2025

Commercial code: W43555001

Concentration: 1mg

Pharmaceutical form: powder + solvent for injection

Quantity: 5

Product type: original

Price: 422.90 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: FERRING GMBH - GERMANIA

Holder: FERRING GMBH - GERMANIA

Number: 10495/2018/01

Shelf life: 3 years

Pharmaceutical forms available for terlipressin

Concentrations available for terlipressin

0.12mg/ml, 0.2mg/ml, 1mg

Other substances similar to terlipressin